However, one must interpret the metabolic sequelae of obesity as a spectrum, ranging from metabolically healthy obesity (normoglycemia and insulin sensitivity) to the metabolically unhealthy phenotype, comprising the consequent ill-stages of insulin resistance, progressive dysglycemia and established T2DM. This evidence concerns the gene INS and obesity disorder.